Chemopreventive effect of zingerone against colon carcinogenesis induced by 1,2-dimethylhydrazine in rats

European Journal of Cancer Prevention

Volumn 23, Issue 5, 2014, Pages 361-371

  Vinothkumar, Rajenderan ^a   Vinothkumar, Rajamanickam ^a   Sudha, Mani ^a   Nalini, Namasivayam ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

1,2 dimethylhydrazine; aberrant crypt foci; lipid peroxidation; zingerone

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ALKENE DERIVATIVE; ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROXYL RADICAL; LIPID; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ZINGERONE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARCINOGEN; GUAIACOL;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; COLON CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; GINGER; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ABERRANT CRYPT FOCI; ANALOGS AND DERIVATIVES; ANIMAL; CARCINOGENESIS; CHEMICALLY INDUCED; COLONIC NEOPLASMS; DRUG EFFECTS; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; WISTAR RAT;

1,2-DIMETHYLHYDRAZINE; ABERRANT CRYPT FOCI; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CARCINOGENESIS; CARCINOGENS; COLONIC NEOPLASMS; GUAIACOL; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84905373301     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32836473ac     Document Type: Article

References (59)

1. Aranganathan S, Panneer Selvam J, Nalini N (2009). Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesis. Invest New Drugs 27:203-213.
2. Arya P, Madhu K (2011). Chemoprevention by Triticum aestivum of mouse skin carcinogenesis induced by DMBA and croton oil: association with oxidative status. Asian Pac J Cancer Prev 12:143-148.
3. Bird RP (1995). Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93:55-71.
4. Bird RP, Good CK (2000). The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 113:395-402.
5. Bouayed J, Bohn T (2010). Exogenous antioxidants - double-edged swords in cellular redox state. Oxid Med Cell Longev 3:228-237.
6. Brady JF, Li D, Ishizaki H, Yang CS (1998). Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities. Cancer Res 48:3937-3940.
7. Carlberg I, Mannervik B (1985). Glutathione reductase. Methods Enzymol 113:484-490.
8. Choudhary G, Hansen H (1998). Human health perspective on environmental exposure to hydrazines; a review. Chemosphere 37:801-843.
9. Chung SW, Kim MK, Chung JH, Kim DH, Choi JS, Anton S, et al. (2009). Peroxisome proliferator-activated receptor activation by a short-term feeding of zingerone in aged rats. J Med Food 12:345-350.
10. Desai ID (1971). Vitamin E analysis methods for animal tissues. Methods Enzymol 105:138-147.
11. Ellman GL (1959). Tissue sulphydryl groups. Arch Biochem Biophys 82:70-77.
12. Elzbieta S, Stanislaw S, Mariusz K, Bogdan Z, Luiza KK, Mariola S (2005). Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol 11:403-406.
13. Estabauer H, Eckl P, Ortner A (1990). Possible mutagens derived from lipids and lipid precursors. Mutat Res 238:223-233.
14. Folhe L, Gunzler WA (1984). Assays of glutathione peroxidase. Methods Enzymol 105:114-121.
15. Fujimitsu Y, Nakanishi H, Inada K, Yamachika T, Ichinose M, Fukami H, et al. (1996). Development of aberrant crypt foci involves a fission mechanism as revealed by isolation of aberrant crypts. Jpn J Cancer Res 12: 1199-1203.
16. Ghayur MN, Gilani AH (2005). Pharmacological basis for the medicinal use of ginger in gastrointestinal disorders. Dig Dis Sci 50:1889-1897.
17. Gopalan P, Jensen DE, Prabhakar D, Lotlikar PD (1992). Glutathione conjugation of microsome-mediated and synthetic aflatoxin B1-8,9-oxide by purified glutathione S-transferases from rats. Cancer Lett 64:225-233.
18. Gurdip S, Kapoor IP, Singh P, de Heluani CS, de Lampasona MP, Catalan CA (2008). Chemistry, antioxidant and antimicrobial investigations on essential oil and oleoresins of Zingiber officinale. Food Chem Toxicol 46:3295-3302.
19. Heber D (2004). Vegetables, fruits and phytoestrogens in the prevention of diseases. J Postgrad Med 50:145-149.
20. Hu Y, Rosen DG, Zhou Y, Feng L, Yang G, Liu J (2005). Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. J Biol Chem 47: 39485-39492.
21. Inokuma T, Haraguchi M, Fujita F, Tajima Y, Kanematsu T (2009). Oxidative stress and tumor progression in colorectal cancer. Hepatogastroenterology 56:343-347.
22. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, et al. (1997). Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275:1649-1652.
23. Jen J, Powell SM, Papadopoulus N (1994). Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54:5523-5526.
24. Jiang ZY, Hunt JV, Wolff SP (1993). Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxides in low density lipoprotein. Anal Biochem 202:384-389.
25. Kabuto H, Nishizawa M, Tada M, Higashio C, Shishibori T, Kohno M (2005). Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum. Neurochem Res 30:325-332.
26. Kakkar P, Das B, Viswanathan PN (1984). A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 2:130-132.
27. Karthikkumar V, Sivagami G, Victor ASJ, Nalini N (2012). The effect of rosmarinic acid on 1,2-dimethylhydrazine induced colon carcinogenesis. Exp Toxicol Pathol 4:409-418.
28. Kim Y, Mason JB (1996). Nutrition chemoprevention of gastrointestinal cancers: a critical review. Nutr Rev 54:259-279.
29. Komatsu D, Kato M, Nakayama J, Miyagawa S, Kamata T (2008). NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression. Oncogene 34:4724-4732.
30. Kucuk O, Churley M, Goodman MT (1994). Increased plasma level of cholesterol- 5b, 6b epoxide in endometrial cancer patients. Cancer Epidemiol Biomark Prev 3:571-575.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
32. Magnuson BA, Bird RP (1993). Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methyl nitrosourea by feeding cholic acid. Cancer Lett 68:15-23.
33. Makiya N (2008). Reactive oxygen species in tumor metastasis. Cancer Lett 266:53-59.
34. McLellan EA, Medline A, Bird RP (1991). Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis 12:2093-2098.
35. Michiels C, Martine R, Olivier T, Remacle J (1994). Importance of SE-glutathione peroxidase, catalase, and CU/ZN-SOD for cell survival against oxidative stress. Free Radic Bio Med 17:235-248.
36. Mori H, Tanaka T, Sugie S, Yoshimi N, Kawamori T, Hirose Y, Ohnishi M (1997). Chemoprevention by naturally occurring and synthetic agents in oral, liver and large bowel carcinogenesis. J Cell Biochem Suppl 27:35-41.
37. Newell LE, Heddle JA (2004). The potent colon carcinogen 1,2-dimethylhydrazine induces mutations primarily in the colon. Mutat Res 564:1-7.
38. Ohkawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358.
39. Omaye ST, Turnbull JD, Sauberlich HE (1979). Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol 62:3-11.
40. Rahman K (2007). Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2:219-236.
41. Rajeshkumar NV, Kuttan R (2003). Modulation of carcinogenic response and antioxidant enzymes of rats administered with 1,2-dimethylhydrazine by Picroliv. Cancer Lett 191:137-143.
42. Rao BN, Rao BS (2010). Antagonistic effects of zingerone, a phenolic alkanone against radiation induced cytotoxicity, genotoxicity, apoptosis and oxidative stress in Chinese hamster lung fibroblast cells growing in vitro. Mutagenesis 76:9577-9587.
43. Rao BN, Rao BS, Aithal BK, Kumar MR (2009). Radiomodifying and anticlastogenic effect of zingerone on Swiss albino mice exposed to whole body gamma radiation. Mutat Res 677:33-41.
44. Recknagel RO, Glende EA (1984). Spectrophotometric detection of lipid conjugated dienes. Methods Enzymol 105:331-337.
45. Roncucci L, Stamp D, Medline A, Cullen JB, Bruce WR (1991). Identification and quantification of aberrant crypt foci and micro adenomas in the human colon. Hum Pathol 22:287-294.
46. Shin SG, Kim JY, Chung HY, Jeong JC (2005). Zingerone as an antioxidant against peroxynitrite. J Agric Food Chem 53:7617-7622.
47. Sinha AK (1972). Colorimetric assay of catalase. Anal Biochem 47:389-394.
48. Sivagami G, Karthikkumar V, Balasubramanian T, Nalini N (2012). The modulatory influence of p-methoxycinnamic acid, an active rice bran phenolic acid, against 1,2-dimethylhydrazine-induced lipid peroxidation, antioxidant status and aberrant crypt foci in rat colon carcinogenesis. Chem Biol Interact 196:11-22.
49. Srikhande SV, Saoji RR, Barreto SG, Kakade AC, Water SD, Aahire SB, et al. (2007). Outcomes of resection for rectal cancer in India, the impact of the double stapling technique. World J Surg Oncol 5:35-40.
50. Stone WL, Papas AM (1997). Tocopherols and the etiology of colon cancer. J Natl Cancer Inst 89:1006-1014.
51. Tanaka T, Kawabata K, Kakumoto M, Hara A, Murakami A, Kuki W, et al. (1998). Citrus auraptene exerts dose dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drugmetabolizing enzymes. Cancer Res 58:2550-2556.
52. Trachootham D, Alexandre J, Huang P (2009). Targeting cancer cells by ROS mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8:579-591.
53. Vriens J, Nilius B, Vennekens R (2008). Herbal compounds and toxins modulating TRP channels. Curr Neuropharmacol 6:79-96.
54. Wargovich MJ, Chen CD, Jimenez A (1996). Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev 5:355-360.
55. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. (1997). Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112:594-642.
56. World Health Organization (2007). Cancer fact sheet no. 297. Geneva, Switzerland: WHO.
57. World Health Organization (2008). World Health Statistics; ISBN 978 92 4 0682740. Geneva, Switzerland: WHO.
58. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H (1995). Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression? Cancer 75:1527-1533.
59. Zalewski B (2004). Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features. World J Gastroenterol 10: 583-585.